Benjakul Extract and Loratadine for Treatment Allergic Rhinitis Patients
Status:
Completed
Trial end date:
2018-03-31
Target enrollment:
Participant gender:
Summary
1. To compare the effectiveness of Benjakul extract capsules at 300 mg per day with
Loratadine drug in the treatment of allergic rhinitis patients in small group (Clinical
Trial Phase II).
2. To study the safety and side effects of Benjakul extract capsules 300 mg per day and
Loratadine drug for allergic rhinitis patients.